chr19-1220395-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The ENST00000326873.12(STK11):c.487G>C(p.Gly163Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G163D) has been classified as Pathogenic.
Frequency
Consequence
ENST00000326873.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.487G>C | p.Gly163Arg | missense_variant | 4/10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.487G>C | p.Gly163Arg | missense_variant | 4/9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1754G>C | non_coding_transcript_exon_variant | 5/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.487G>C | p.Gly163Arg | missense_variant | 4/10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.487G>C | p.Gly163Arg | missense_variant | 4/9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.115G>C | p.Gly39Arg | missense_variant | 6/12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2016 | The p.G163R variant (also known as c.487G>C), located in coding exon 4 of the STK11 gene, results from a G to C substitution at nucleotide position 487. The glycine at codon 163 is replaced by arginine, an amino acid with dissimilar properties. This variant is in the highly conserved protein kinase domain of the STK11 gene. It has been reported in multiple individuals in different populations with a clinical diagnosis of Peutz-Jeghers syndrome (Barker D et al. Int J Gynecol Pathol. 2010 Jan;29(1):27-32; Fu J, Genet Test Mol Biomarkers 2015 Sep;19(9):528-31). Another alteration at this position, p.G163D, has been reported as a mutation in a patient with Peutz-Jeghers syndrome and was shown to lead to severely impaired but detectable kinase activity (Lim W Gastroenterology. 2004 Jun;126(7):1788-94; Ylikorkala A Hum Mol Genet. 1999 Jan;8(1):45-51). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6328 samples (12656 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.002% (greater than 125000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at